Academic literature on the topic 'Cancer du sein – Facteurs de risque'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer du sein – Facteurs de risque.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cancer du sein – Facteurs de risque"
Nkondjock, André, and Parviz Ghadirian. "Facteurs de risque du cancer du sein." médecine/sciences 21, no. 2 (February 2005): 175–80. http://dx.doi.org/10.1051/medsci/2005212175.
Full textCohen-Haguenauer, Odile. "Prédisposition héréditaire au cancer du sein (2)." médecine/sciences 35, no. 4 (April 2019): 332–45. http://dx.doi.org/10.1051/medsci/2019072.
Full textEspié, Marc, Marjorie Lalloum, and Florence Coussy. "Épidémiologie et facteurs de risque du cancer du sein." Soins 58, no. 776 (June 2013): 22–24. http://dx.doi.org/10.1016/j.soin.2013.04.003.
Full textTardivon, A., and C. Malhaire. "Cancer du sein (I). Épidémiologie, facteurs de risque, imagerie." EMC - Radiologie et imagerie médicale - Génito-urinaire - Gynéco-obstétricale - Mammaire 4, no. 3 (January 2009): 1–30. http://dx.doi.org/10.1016/s1879-8543(09)70668-8.
Full textEl Hanchi, Z., R. Berrada, A. Fadli, D. Ferhati, R. Brahmi, A. Baydada, A. Kharbach, and A. Chaoui. "Cancer du sein bilatéral. Incidence et facteurs de risque." Gynécologie Obstétrique & Fertilité 32, no. 2 (February 2004): 128–34. http://dx.doi.org/10.1016/j.gyobfe.2003.01.002.
Full textClavel-Chapelon, Françoise, and Pascale Gerbouin-Rérolle. "L’étude E3N : cancer du sein et facteurs de risque." Annales de Pathologie 32, no. 5 (November 2012): S34. http://dx.doi.org/10.1016/j.annpat.2012.09.007.
Full textFrikha, Nadia, and Mehdi Chlif. "Un aperçu des facteurs de risque du cancer du sein." Bulletin de l'Académie Nationale de Médecine 205, no. 5 (May 2021): 519–27. http://dx.doi.org/10.1016/j.banm.2020.10.018.
Full textHill, C., P. This, and F. Doyon. "1421 Cancer du sein : epidemiologie, facteurs et evaluation du risque." Journal de Radiologie 86, no. 10 (October 2005): 1186. http://dx.doi.org/10.1016/s0221-0363(05)74910-6.
Full textPlu-Bureau, Geneviève, and Brigitte Raccah-Tebeka. "La balance bénéfices-risques des contraceptions hormonales estroprogestatives." médecine/sciences 38, no. 1 (January 2022): 59–69. http://dx.doi.org/10.1051/medsci/2021238.
Full textDrissi, H., F. E. Imad, K. Bendahhou, D. Radallah, and A. Benider. "Cancer du sein et ses facteurs de risque (étude cas-témoin)." Revue d'Épidémiologie et de Santé Publique 64 (May 2016): S144—S145. http://dx.doi.org/10.1016/j.respe.2016.03.075.
Full textDissertations / Theses on the topic "Cancer du sein – Facteurs de risque"
Hannoun, Djohar. "Etude des facteurs de risque du cancer du sein en Algérie." Montpellier 1, 2001. http://www.theses.fr/2001MON1T025.
Full textMERLIN, MARIE-FRANCOISE. "Particularites des facteurs de risque du cancer du sein en picardie." Amiens, 1992. http://www.theses.fr/1992AMIEM106.
Full textLE, KIEU GIANG. "Facteurs de risque de recidive locale apres traitement conservateur du sein." Clermont-Ferrand 1, 1994. http://www.theses.fr/1994CLF1MS39.
Full textSAUVE, CATHERINE. "Facteurs de risque psycho-affectifs des cancers du sein chez la femme." Toulouse 3, 1989. http://www.theses.fr/1989TOU31049.
Full textLecarpentier, Julie. "Étude des facteurs modificateurs du risque de cancer du sein des femmes à risque génétique élevé." Phd thesis, Université Paris Sud - Paris XI, 2012. http://tel.archives-ouvertes.fr/tel-00910388.
Full textHamdi, Yosr. "Evaluation of the association between common genetic variants and breast cancer risk." Doctoral thesis, Université Laval, 2017. http://hdl.handle.net/20.500.11794/28384.
Full textBreast cancer is the most common malignancy in women. A set of environmental and genetic factors are involved in this complex disease. This project focused on the genetic components of breast cancer susceptibility and breast cancer risk modification in BRCA1 and BRCA2 mutation carriers. Currently, about half of the inherited susceptibility to breast cancer can be imputed to a combination of high-, intermediate-, and low-risk alleles. Thus, many as yet unknown susceptibility loci remain to be identified. Moreover, recent studies have provided evidence for the involvement of genetic risk factors that might considerably modify the risk of developing breast cancer in BRCA1 and BRCA2 mutation carriers. Furthermore, genome-wide association studies have shown that several genetic variants within non-coding gene regions are associated with breast cancer risk. In this project, we focused on regulatory gene variants and their association with breast cancer risk. The project was divided in two parts. In the first section, we evaluated the direct association between single-nucleotide polymorphisms associated with differential allelic expression and breast cancer risk in order to identify new loci of breast cancer susceptibility. In the second part, we evaluated the functional impact on gene expression of variants identified within the promoter regions of selected candidate genes and then, characterize the functional impact of these variants. In summary, the first part of this project has led to the identification of a new low-penetrance locus associated with breast cancer risk on the 4q21 locus (rs11099601; odds ratio=1.05, p= 6.4 x 10-6), and two new modifiers of breast cancer risk in BRCA1 mutations carriers (11q22.3 locus and the wild type allele of BRCA1). The second part of the project allowed us to describe new functional variants within the promoters of the selected breast cancer gene candidates. Other association studies in larger cohorts and further functional analysis will be required to confirm these results, which will allow their inclusion in breast cancer risk prediction tools and thus ensure a more accurate estimation of breast cancer risk.
Lemarchand, Clémentine. "Facteurs de risque de cancers hormono-dépendants en population agricole au sein de la cohorte agriculture et cancer." Caen, 2015. http://www.theses.fr/2015CAEN3159.
Full textAgriculture is an occupational environment which expose to a large range of agents (pesticides, dust…), frequently associated with occurrence of several diseases. Only pesticides have been often studied but the role of specific pesticides remains poorly documented especially in France, first pesticide consumer among European countries. The aim of the thesis was to identify the determinants related to hormone-related cancers. This project relies on the data of the cohort AGRICAN involving more than 180 000 subjects. More than 11 000 cancer cases have been identified by regular linkage with cancer registries (2538 prostate cancers and 1087 breast cancers). Apart from tobacco-related cancers with a lower incidence, some cancers were more frequent in the cohort (prostate, non-Hodgkin lymphoma, multiple myeloma, skin melanoma and lip cancers). Insecticide applicators on cattle, mainly those with the largest number of animals, pesticide applicators on specific crops (fruit growing, cereals, potatoes and tobacco) and specially those who do not wear protective gloves, people performing reentry tasks in those same sectors had a greater prostate cancer risk. Potential exposure to organochlorine insecticides (estimated using the crop-exposure matrix PESTIMAT) also increased prostate cancer risk. Although female farmers had an overall decreased risk of breast cancer, peas and vegetables growers had an increased risk. Results seem different according to menopausal status
Brulin-Lemanski, Claire. "Récidives locales des cancers du sein après traitement conservateur par chirurgie-radiothérapie : facteurs de risque et conséquences des échecs locaux à propos de 423 cas." Montpellier 1, 1997. http://www.theses.fr/1997MON11037.
Full textIssa, Elissar. "La méthylation de l'ADN dans les tissus mammaires normaux et le risque de cancer du sein controlatéral." Master's thesis, Université Laval, 2018. http://hdl.handle.net/20.500.11794/29819.
Full textINTRODUCTION: Women with breast cancer (BC) have an increased risk of developing a contralateral breast cancer (CBC). This risk is 3 to 5 times higher than the risk of developing primary breast cancer by women in the general population. The methylation of DNA is known to be involved in the development of cancer, and changes in methylation profile in breast tumor cells have already been observed. OBJECTIVE: Our aims are to identify changes in global DNA methylation as well as the differentially methylated sites that are associated with an increased risk of developing CBC. METHODS: This is a case-control study (1:1) nested in a cohort of 1242 women. Cases (n = 20) were diagnosed with CBC during follow-up but not Controls (n = 20). Cases were matched to controls for CSC risk factors such as year of surgery, age, family history of BC, and the treatment. The DNA was extracted from normal breast tissue (to minimize field effect) more than 1 cm from the paraffin-embedded tumor and the methylation was measured by Illumina Infinium 450K. RESULTS: Global DNA hypomethylation was associated with a decreased risk of CBC with an odd ratios and a confidence interval at 95% = 0.714 (0.227-2.251), but this association was not significant. In addition, non-significant hypomethylation in 3'UTR and intergenic regions was observed in cases compared with controls. We have also found hypermethylation of the ELOVL6, DACT2, LHX2, GABRA5 and OSBP2 genes that may be associated with the risk of developing CBC. CONCLUSION: Global DNA hypomethylation from adjacent normal tissues may be predictive of the risk of CBC. In addition, hypermethylation of specific genes such as CCDC108, ELOVL6, DACT2, LHX2, GABRA5 and OSBP2 in normal breast tissues may therefore be useful as a clinical biomarker of CBC if our results were validated in a larger cohort.
Slim, Ferial Amira. "Une isoforme de Allograft Inflammatory Factor-1 (AIF1) impliquée dans le cancer du sein." Master's thesis, Université Laval, 2018. http://hdl.handle.net/20.500.11794/34495.
Full textBreast cancer (BC) represents one of the most common and dangerous cancers in terms of mortality and incidence among women worldwide. It is even more recurrent in developed countries including Canada [2]. BC is a complex and multifactorial disorder, its severity and response to treatment differs from case to case and its diagnosis can be tricky due to the heterogeneity of the pathology. Thus, this project aims to study a potential BC risk factor that can be used for diagnosis and treatment of BC patients. Allograft Inflammatory Factor-1 (AIF1) is a protein involved in many inflammatory diseases that has also been associated with cancer, however, in most studies, only one isoform has been analyzed. Our analyses of the transcriptional profile of individuals from French Canadian families with high risk of BC (BRCA1/BRCA2 or not-BRCA1/2 (BRCAX)) identified significantly and differentially expressed transcripts between the different groups. Among them, two AIF1 splice variants were highly overexpressed in the BRCAX lymphoblastoid cell lines (LCLs) of the affected sister comparatively with her non-affected sister. Our gene expression analysis revealed that both isoforms were mostly expressed in the least aggressive BC and this expression resulted from the tumor microenvironment, AIF1v1 being mostly expressed by lymphocytes and AIF1v3 by activated macrophages. We also demonstrated the effect of docosahexaenoic omega-3 fatty acids (DHA) on the downregulation of AIF1 isoforms expression in BRCAX LCLs. Lastly, our data showed that AIF1 isoforms expression in breast tumors and breast adipose tissue correlated with metabolic and clinical parameters of BC patients. Ultimately, all data and information resulting from this study represent a major breakthrough for the scientific community and the cancer research field since it is the first study on AIF1v1 and its involvement in BC, breast tumor microenvironment and inflammatory reaction.
Books on the topic "Cancer du sein – Facteurs de risque"
Canadian Breast Cancer Initiative. Working Group on Primary Prevention of Breast Cancer. Summary report : review of lifestyle and environmental risk factors for breast cancer : report of the Working Group on Primary Prevention of Breast Cancer, Canadian Breast Cancer Initiative =: Rapport sommaire : examen des facteurs de risque de cancer du sein liés au style de vie et à l'environnement : rapport du Groupe de travail sur la prévention primaire du cancer du sein, Initiative canadienne sur le cancer du sein. Edited by Tomlin Barbara, Aronson Kristan J, and Initiative canadienne sur le cancer du sein. Groupe de travail sur la prévention primaire du cancer du sein. Ottawa, Ont: Health Canada = Santé Canada, 2001.
Find full textOral contraceptives & breast cancer. Washington, D.C: National Academy Press, 1991.
Find full textCatherine, Solano, ed. Prévenir: Cancers, Alzheimer, infarctus, et vivre en forme plus longtemps. Paris: Librarie générale française, 2007.
Find full textCancer risk by social class and occupation: A survey of 109,000 cancer cases among Finns of working age. Basel: Karger, 1995.
Find full textL, Spitzer Hugh, ed. Receptor-mediated biological processess: Implications forevaluating carcinogenesis : proceedings of the Sixth International Conference on Carcinogenesis and Risk Assessment, held in Austin, Texas, on December 8-11, 1992. New York: Wiley-Liss, 1994.
Find full textcancer, Société canadienne du, Action cancer Ontario, and Agence de santé publique du Canada., eds. Le cancer chez les jeunes adultes au Canada. Toronto: Action cancer Ontario, 2006.
Find full textQuel est votre risque de developper un cancer du sein? [Bethesda, Md.?: National Cancer Institute, 1999.
Find full textNational Cancer Institute (U.S.), ed. Quel est votre risque de developper un cancer du sein? [Bethesda, Md.?: National Cancer Institute, 1999.
Find full textNational Cancer Institute (U.S.), ed. Quel est votre risque de développer un cancer du sein? [Bethesda, Md.?: National Cancer Institute, 1999.
Find full textBenoît, Hervé-Bazin, and Courtois Bruno, eds. Le risque cancérogène du plomb: Évaluation du risque cacérogène lié à l'exposition professionnelle au plomb et à ses composés inorganiques. Les Ulis: Institut national de Recherche et de Sécurit, 2004.
Find full textBook chapters on the topic "Cancer du sein – Facteurs de risque"
Zelek, L., and T. Bouillet. "Mode de vie et cancer du sein: Les facteurs de risque non hormonaux." In Cancer du sein, 191–95. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_14.
Full textTerki, K., N. Messid, I. Meguenni, F. Dablaoui, Z. Djaroud, L. Mokhtari, and B. Chafi. "Cancer du sein : épidémiologie et facteurs de risque (EHUo Oran 2008–2009)." In Cancer du sein : surdiagnostic, surtraitement, 257–58. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_60.
Full textFitoussi, A. "Prise en compte de tous les facteurs influençant la prise en charge des patientes à haut risque." In Cancer du sein, 35–41. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_4.
Full textHeiss, N., V. Rousson, A. Ifticene-Treboux, H. A. Lehr, and J. F. Delaloye. "Les facteurs de risque pour une atteinte des marges après la résection conservatrice d’un cancer du sein." In Cancer du sein : surdiagnostic, surtraitement, 360–61. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_108.
Full textArrault-Chaya, M. "Facteurs de risque et prévention du lymphœdème après traitement du cancer du sein." In Acquis et limites en sénologie / Assets and limits in breast diseases, 205–8. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0396-8_28.
Full textBarouagui, S., C. Zaoui, R. Senhadji, and F. Z. El Kébir. "Âge, facteurs hormonaux endogènes et exogènes et risque du cancer du sein dans l’Ouest algérien." In Acquis et limites en sénologie / Assets and limits in breast diseases, 422. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0396-8_84.
Full textdos Santos, G., B. Téhard, and F. Clavel-Chapelon. "Étude de l’activité physique sur le risque de cancer du sein." In Cancer du sein, 19–22. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-71478-8_4.
Full textSpano, J. P. "Nouveauté et analyse critique des facteurs de pronostic et de réponses thérapeutiques." In Cancer du sein avancé, 49–51. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-72615-6_5.
Full textEspié, M., A. S. Hamy, and S. Frank. "Contraception orale, traitement hormonal de la ménopause, inducteurs de l’ovulation et risque de cancer du sein." In Cancer du sein, 183–90. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_13.
Full textCoutant, C., E. Chéreau, C. Bezu, E. Darai, S. Uzan, and R. Rouzier. "Points communs et différences entre les divers nomogrammes validés pour le calcul du risque d’envahissement ganglionnaire." In Cancer du sein, 63–76. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_6.
Full textConference papers on the topic "Cancer du sein – Facteurs de risque"
Radoï, L., G. Menvielle, B. Lapôtre-Ledoux, I. Stücker, and L. Danièle. "Fractions de risque attributable de cancer de la cavité buccale à des facteurs de risque environnementaux et médicaux : l’étude ICARE." In 64ème Congrès de la SFCO, edited by S. Boisramé, S. Cousty, J. C. Deschaumes, V. Descroix, L. Devoize, P. Lesclous, C. Mauprivez, and T. Fortin. Les Ulis, France: EDP Sciences, 2016. http://dx.doi.org/10.1051/sfco/20166402022.
Full textReports on the topic "Cancer du sein – Facteurs de risque"
de Marcellis-Warin, Nathalie, and Geneviève Dufour. Analyse des événements indésirables liés à la prestation des soins de santé : Démarche structurée et grille d'analyse. CIRANO, June 2003. http://dx.doi.org/10.54932/hytf7762.
Full text